Organ transplantation is a surgical procedure used when a patient's organ no longer functions properly. Heart, liver, and kidney transplantation are the most performed organ transplantation procedures. However, the rising prevalence of chronic diseases is necessitating organ transplantation for organs such as lungs, pancreas, cornea, and vascular tissues. Organ transplantation is regarded as one of the most significant advances in modern medicine.
The rise in chronic diseases that cause damage to the functions of the heart, lungs, liver, kidney, and other organs is leading to an increase in the number of organ transplants. Moreover, excessive alcohol consumption leads to liver cirrhosis, ultimately resulting in a liver transplant. A poor diet contributes to the development of renal and hepatic illnesses, which can lead to organ failure. This is another factor contributing to the growth of organ transplantation and, therefore, the preservation solutions market. Transplantation surgeries are becoming more common worldwide. For instance, in Spain, the Organizacion Nacional de Transplantes (ONT) manages the program, where growth in donations has been significant, from 14.3 per million population in 1980 to 49 deceased donors per million population in 2019, i.e., an increase to 2,302 donors in 2019. Furthermore, as per the ONT, a 40% increase in donors has been observed from 2016 to 2021. By adopting a “50-22” directive, the goal was to reach 50 donors per million population by 2022.
The public-private partnership, in collaboration with transplant coordinators, has made a significant contribution to the improvement of organ transplantation. Both developing and developed countries have seen an increase in the number of organ transplant surgeries.
The market in Europe is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The market is driven by the factors such as increasing government, innovative technology and products, and growing prevalence of chronic diseases in the region.
Germany is an attractive market due to its consistent growth and innovative approach toward the healthcare sector. According to Federal Statistical Office, health expenditure in Germany amounted to US$ 474 billion in 2021. The demand for highly innovative technologies and diagnostic, therapeutic, and minimally invasive equipment remains high worldwide.
Rising geriatric population and increasing prevalence of chronic diseases are expected to propel market growth. With the growing age, many organs start to malfunction or become dysfunctional giving rise to organ transplantation procedures. For instance, according to the WHO, in Germany, 34% of people aged 65 and above reported having one chronic disease, and 24% of people aged 65 and above reported having two chronic diseases.
In addition, public health issues resulting in chronic health disorders also give rise to organ transplantation procedures. For instance, according to the WHO, about four in ten deaths in Germany result from behavioral risk factors, including dietary risks, smoking, alcohol consumption, and low physical activity. In 2021, ~19% of adults were obese in Germany. Obesity gives rise to various other health-related problems.
Strategic insights for the Europe Organ Preservation Solutions provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Europe Organ Preservation Solutions refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.Europe Organ Preservation Solutions Strategic Insights
Europe Organ Preservation Solutions Report Scope
Report Attribute
Details
Market size in 2023
US$ 69.90 Million
Market Size by 2028
US$ 99.51 Million
Global CAGR (2023 - 2028)
7.3%
Historical Data
2021-2022
Forecast period
2024-2028
Segments Covered
By Type
By Application
By Organ Type
By End User
Regions and Countries Covered
Europe
Market leaders and key company profiles
Europe Organ Preservation Solutions Regional Insights
Europe Organ Preservation Solution Market Segmentation
The Europe organ preservation solution market is segmented into type, application, organ type, end user, and country.
Based on type, the Europe organ preservation solution market is segmented into university of wisconsin solution, custodiol htk, perfadex, hypothermosol, and others. The university of wisconsin solution segment registered the largest Europe organ preservation solution market share in 2023.
Based on application, the Europe organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest Europe organ preservation solution market share in 2023.
Based on organ type, the Europe organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held the largest Europe organ preservation solution market share in 2023.
Based on end user, the Europe organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics, The organ transplant centers segment held the largest Europe organ preservation solution market share in 2023.
Based on country, the Europe organ preservation solutions market has been categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe organ preservation solutions market share in 2023.
Accord Healthcare; Dr. Franz Koehler Chemie GmbH; Lifeline Scientific, Inc; OrganOx Limited; Paragonix Technologies, Inc; and TransMedics are the leading companies operating in the Europe organ preservation solutions market in the region.
The Europe Organ Preservation Solutions Market is valued at US$ 69.90 Million in 2023, it is projected to reach US$ 99.51 Million by 2028.
As per our report Europe Organ Preservation Solutions Market, the market size is valued at US$ 69.90 Million in 2023, projecting it to reach US$ 99.51 Million by 2028. This translates to a CAGR of approximately 7.3% during the forecast period.
The Europe Organ Preservation Solutions Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Organ Preservation Solutions Market report:
The Europe Organ Preservation Solutions Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Organ Preservation Solutions Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Organ Preservation Solutions Market value chain can benefit from the information contained in a comprehensive market report.